Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) Featured in Virtual Coverage of the KCSA Mental Health Investor Conference
Filament Health (OTCQB: FLHLF) (NEO: FH) is a clinical-stage natural psychedelic drug development company. The company believes that safe, standardized, naturally derived psychedelic medicines can improve the lives of many, and its mission is to see them in the hands of everyone who needs them as soon as possible. Filament's platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines.…